v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Revenue $ 7,350 $ 9,002
Cost of revenue 4,508 5,756
Gross profit 2,842 3,246
Operating expenses    
Research and development 945 1,556
Sales and marketing 1,376 2,332
General and administrative 1,210 1,364
Intangible amortization 226 308
Total operating expenses 3,757 5,560
Operating profit (loss) (915) (2,314)
Other income, net 30 164
Income (loss) before income taxes (885) (2,150)
Income tax benefit (expense) 60 (7)
Net income (loss) (1) [1] $ (825) $ (2,157)
Basic $ (0.05) $ (0.14)
Diluted $ (0.05) $ (0.14) [2]
Weighted-average number of common shares outstanding:    
Basic (shares) 15,665 15,455
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options (2) [3] 0 0
Diluted (shares) 15,665 15,455
[1] Net income (loss) and comprehensive income (loss) are the same for the periods reported.
[2] {F|ahBzfndlYmZpbGluZ3MtaHJkcmoLEgZYTUxEb2MiXlhCUkxEb2NHZW5JbmZvOjZlN2VmNDIwNTljODRkNDBhNmMwZTIwYWRhNTMyNDc4fFRleHRTZWxlY3Rpb246MjU2NjQ3RUFGM0YzNTBBODQ3RkI3RDJFNEJGRDc3REIM}
[3] The Company had 0.9 million and 1.0 million shares represented by common stock equivalents for the three months ended June 30, 2020 and June 30, 2019, respectively, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation.

Source